The state-run Indian Council of Medical Research (ICMR) and privately-held Bharat Biotech this month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers. It is the most advanced Indian experimental vaccine. He reiterated the government’s plan was to immunise 200 million to 250 million Indians by July. Vardhan, however, said in September the government could opt for emergency vaccine authorisation, particularly for the elderly and people in high-risk workplaces. India on Sunday recorded 45,209 new infections, taking the total to 9.09 million, only behind that of the United States.

Source: bd News24 November 22, 2020 17:03 UTC